153 related articles for article (PubMed ID: 25339018)
1. Associations between TLR9 polymorphisms and cancer risk: evidence from an updated meta-analysis of 25,685 subjects.
Wan GX; Cao YW; Li WQ; Li YC; Zhang WJ; Li F
Asian Pac J Cancer Prev; 2014; 15(19):8279-85. PubMed ID: 25339018
[TBL] [Abstract][Full Text] [Related]
2. Gene Polymorphisms of Toll-Like Receptor 9 -1486T/C and 2848G/A in Cervical Cancer Risk.
Mu X; Zhao J; Yuan X; Zhao X; Yao K; Liu Y; Zhao X
Int J Gynecol Cancer; 2015 Sep; 25(7):1173-8. PubMed ID: 26270118
[TBL] [Abstract][Full Text] [Related]
3. TLR9 polymorphisms and systemic lupus erythematosus risk: an update meta-analysis study.
Wang D; Zhang C; Zhou Z; Pei F
Rheumatol Int; 2016 Apr; 36(4):585-95. PubMed ID: 26643792
[TBL] [Abstract][Full Text] [Related]
4. Lack of association of Toll-like receptor 9 polymorphisms with susceptibility to systemic lupus erythematosus in an Asian population: a meta-analysis.
Li J; Tao JH; Gao W; Fan Y; Lu MM; Li R; Li XP; Ye DQ
Mod Rheumatol; 2012 Aug; 22(4):550-6. PubMed ID: 22228476
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus and toll-like receptor 9 polymorphisms: A meta-analysis of genetic association studies.
Lee YH; Song GG
Lupus; 2023 Jul; 32(8):964-973. PubMed ID: 37265090
[TBL] [Abstract][Full Text] [Related]
6. The TLR9 gene polymorphisms and the risk of cancer: evidence from a meta-analysis.
Zhang L; Qin H; Guan X; Zhang K; Liu Z
PLoS One; 2013; 8(8):e71785. PubMed ID: 23990988
[TBL] [Abstract][Full Text] [Related]
7. [The correlation between polymorphisms of Toll-like receptor 2 and Toll-like receptor 9 and susceptibility to gastric cancer].
Zeng HM; Pan KF; Zhang Y; Zhang L; Ma JL; Zhou T; Su HJ; Li WQ; Li JY; You WC
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):588-92. PubMed ID: 22041559
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
9. Association of Polymorphisms in the Atrial Natriuretic Factor Gene with the Risk of Essential Hypertension: A Systematic Review and Meta-Analysis.
Wang J; Wang Z; Yu C
Int J Environ Res Public Health; 2016 Apr; 13(5):. PubMed ID: 27136577
[TBL] [Abstract][Full Text] [Related]
10. Association between three eNOS polymorphisms and cancer risk: a meta-analysis.
Wu X; Wang ZF; Xu Y; Ren R; Heng BL; Su ZX
Asian Pac J Cancer Prev; 2014; 15(13):5317-24. PubMed ID: 25040995
[TBL] [Abstract][Full Text] [Related]
11. Association of TLR4 and TLR9 gene polymorphisms with cervical HR-HPV infection status in Chinese Han population.
Zhang C; Yang Z; Luo P; Li T; Wang S; Sun F; Gong P; Mei B
BMC Infect Dis; 2023 Mar; 23(1):152. PubMed ID: 36915050
[TBL] [Abstract][Full Text] [Related]
12. TLR9 gene polymorphism (rs187084, rs352140): association with acute rejection and estimated glomerular filtration rate in renal transplant recipients.
Kim TH; Jeong KH; Kim SK; Lee SH; Ihm CG; Lee TW; Moon JY; Yoon YC; Chung JH; Park SJ; Kang SW; Kim YH
Int J Immunogenet; 2013 Dec; 40(6):502-8. PubMed ID: 23758740
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Scott RJ
BMC Cancer; 2010 Jul; 10():382. PubMed ID: 20646321
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 9 polymorphisms and
Susi MD; Lourenço Caroline M; Rasmussen LT; Payão SLM; Rossi AFT; Silva AE; de Oliveira-Cucolo JG
World J Gastrointest Oncol; 2019 Nov; 11(11):998-1010. PubMed ID: 31798780
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: a meta-analysis.
Jing JJ; Li M; Yuan Y
Gene; 2012 May; 499(2):237-42. PubMed ID: 22441122
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of CYP24A1 gene and cancer susceptibility: a meta-analysis including 40640 subjects.
Wang Y; Wang R; Yuan S; Liu X
World J Surg Oncol; 2023 Sep; 21(1):279. PubMed ID: 37670334
[TBL] [Abstract][Full Text] [Related]
17. Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.
Pandey NO; Chauhan AV; Raithatha NS; Patel PK; Khandelwal R; Desai AN; Choxi Y; Kapadia RS; Jain ND
Sci Rep; 2019 Jul; 9(1):9729. PubMed ID: 31278284
[TBL] [Abstract][Full Text] [Related]
18. A genetic variant in the promoter region of Toll-like receptor 9 and cervical cancer susceptibility.
Chen X; Wang S; Liu L; Chen Z; Qiang F; Kan Y; Shen Y; Wu J; Shen H; Hu Z
DNA Cell Biol; 2012 May; 31(5):766-71. PubMed ID: 22059466
[TBL] [Abstract][Full Text] [Related]
19. A Meta-Analysis for Association of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-α rs1800629, and TLR9 rs352140 Polymorphisms with Susceptibility to Cervical Carcinoma.
Parsaeian SF; Asadian F; Karimi-Zarchi M; Setayesh S; Javaheri A; Tabatabaie RS; Dastgheib SA; Golestanpour H; Neamatzadeh H
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3419-3431. PubMed ID: 34837895
[TBL] [Abstract][Full Text] [Related]
20. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
Hamdy S; Osman AM; Zakaria ZA; Galal I; Sobhy M; Hashem M; Allam WR; Abdel-Samiee M; Rewisha E; Waked I; Abdelwahab SF
Arch Virol; 2018 Sep; 163(9):2433-2442. PubMed ID: 29860675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
